{"product_id":"combination-studies-with-the-vascular-disrupting-agent-ca4p-von-andrew-gaya","title":"Combination Studies With The Vascular Disrupting Agent CA4P","description":"\u003cp\u003eThis work represents studies carried out at Mount  Vernon Hospital and UCL, and sponsored by Cancer  Research UK, between 2003 and 2006. Phase I\/II  Clinical trial studies of the vascular disrupting  agent Combretastatin A4 Phosphate (CA4P) are  presented - in combination with cytotoxic  chemotherapy (Paclitaxel and Carboplatin), and  radioimmunotherapy. Dynamic Contrast Enhanced MRI  data from the studies is presented and discussed,  and a supporting immunohistochemistry correlation  study of vascular markers is also presented.\u003c\/p\u003e\u003cdiv class=\"aw-variant-hidden-subtitle-div\" id=\"aw-variant-subtitle-9783838343532\"\u003e\u003ch3\u003eClinical Studies combined with chemotherapy and radioimmunotherapy, and DCE-MRI and  immunohistochemistry correlation\u003c\/h3\u003e\u003c\/div\u003e","brand":"Autorenwelt Shop","offers":[{"title":"Softcover - 9783838343532","offer_id":39498989142109,"sku":"9783838343532","price":79.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/0622\/files\/c849845d-68d6-470a-981a-7029ca058493.jpg?v=1757656147","url":"https:\/\/shop.autorenwelt.de\/en\/products\/combination-studies-with-the-vascular-disrupting-agent-ca4p-von-andrew-gaya","provider":"Autorenwelt Shop","version":"1.0","type":"link"}